Bacitracin
NDC Package 45932-0026-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bacitracin is a medication an antibiotic used to treat certain bacterial eye infections. Marketed by Xellia Pharmaceuticals Aps, this product is identified by NDC 45932-0026 and is authorized under FDA application ANDA203177.

Identification & Billing

NDC Package Code
45932-0026-2
Package Description
10 VIAL in 1 CARTON / 1 INJECTION in 1 VIAL
Product Code
45932-0026
11-Digit Billing Format
45932002602

Clinical Specifications

Proprietary Name
Bacitracin
Dosage Form
-
Usage Information
This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Regulatory & Marketing

Labeler Name
Xellia Pharmaceuticals Aps
FDA Application #
ANDA203177
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-31-2013
End Marketing Date
07-31-2022
Listing Expiration
07-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (45932-0026). Click a package code to view its specific billing and regulatory data.

45932-0026-1
1 VIAL in 1 CARTON / 1 INJECTION in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45932-0026-2 identifies a specific commercial package of 10 vial in 1 carton / 1 injection in 1 vial of Bacitracin, labeled by Xellia Pharmaceuticals Aps. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Xellia Pharmaceuticals Aps on January 31, 2013. The current certification is valid through July 31, 2022.

What are the primary indications for this medication?

This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

How is this Xellia Pharmaceuticals Aps product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45932002602. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
45932-0026-2
11-Digit CMS (5-4-2)
45932-0026-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.